95.20
前日終値:
$96.14
開ける:
$96
24時間の取引高:
370.95K
Relative Volume:
1.08
時価総額:
$3.12B
収益:
$2.32B
当期純損益:
$82.93M
株価収益率:
37.78
EPS:
2.52
ネットキャッシュフロー:
$203.54M
1週間 パフォーマンス:
+0.00%
1か月 パフォーマンス:
+4.26%
6か月 パフォーマンス:
-1.56%
1年 パフォーマンス:
+1.19%
Amedisys Inc Stock (AMED) Company Profile
AMED を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
![]()
AMED
Amedisys Inc
|
95.20 | 3.12B | 2.32B | 82.93M | 203.54M | 2.52 |
![]()
HCA
Hca Healthcare Inc
|
353.92 | 82.53B | 71.59B | 5.78B | 4.95B | 22.49 |
![]()
FMS
Fresenius Medical Care Ag Adr
|
28.07 | 16.47B | 20.87B | 715.14M | 1.67B | 1.2209 |
![]()
DVA
Davita Inc
|
143.63 | 12.58B | 12.67B | 827.68M | 1.42B | 9.27 |
![]()
EHC
Encompass Health Corp
|
115.91 | 11.69B | 5.22B | 422.40M | 269.50M | 4.14 |
![]()
THC
Tenet Healthcare Corp
|
149.06 | 11.51B | 20.97B | 3.13B | 2.39B | 31.21 |
Amedisys Inc Stock (AMED) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2024-07-29 | ダウングレード | Deutsche Bank | Buy → Hold |
2024-07-01 | ダウングレード | William Blair | Outperform → Mkt Perform |
2023-06-07 | ダウングレード | Truist | Buy → Hold |
2023-04-21 | 開始されました | Cantor Fitzgerald | Neutral |
2023-03-13 | 開始されました | Barclays | Equal Weight |
2022-10-27 | ダウングレード | Raymond James | Outperform → Mkt Perform |
2022-08-02 | ダウングレード | UBS | Neutral → Sell |
2022-06-29 | 開始されました | Stifel | Hold |
2022-06-21 | ダウングレード | BofA Securities | Neutral → Underperform |
2022-03-01 | アップグレード | UBS | Sell → Neutral |
2022-02-25 | アップグレード | BMO Capital Markets | Market Perform → Outperform |
2022-02-25 | 繰り返されました | Credit Suisse | Outperform |
2022-02-25 | 繰り返されました | Oppenheimer | Outperform |
2022-02-25 | 繰り返されました | RBC Capital Mkts | Outperform |
2022-02-25 | 繰り返されました | Raymond James | Outperform |
2022-02-25 | 繰り返されました | Truist | Buy |
2021-09-27 | 開始されました | SVB Leerink | Mkt Perform |
2021-09-24 | 開始されました | UBS | Sell |
2021-09-10 | 開始されました | Cowen | Market Perform |
2021-08-10 | 繰り返されました | The Benchmark Company | Buy |
2021-08-05 | ダウングレード | BofA Securities | Buy → Neutral |
2020-08-20 | 再開されました | Barclays | Overweight |
2020-07-30 | 繰り返されました | The Benchmark Company | Buy |
2020-06-18 | アップグレード | The Benchmark Company | Hold → Buy |
2020-05-07 | ダウングレード | The Benchmark Company | Buy → Hold |
2020-03-09 | アップグレード | The Benchmark Company | Hold → Buy |
2020-01-17 | 開始されました | Credit Suisse | Outperform |
2019-11-01 | アップグレード | Robert W. Baird | Neutral → Outperform |
2019-10-22 | 再開されました | Stephens | Equal-Weight |
2019-09-17 | 開始されました | Deutsche Bank | Buy |
2019-05-02 | アップグレード | Raymond James | Mkt Perform → Outperform |
2018-12-14 | 開始されました | Barclays | Equal Weight |
2018-11-16 | 開始されました | UBS | Neutral |
2018-10-30 | アップグレード | The Benchmark Company | Hold → Buy |
2018-07-03 | アップグレード | BofA/Merrill | Neutral → Buy |
2018-03-19 | アップグレード | RBC Capital Mkts | Sector Perform → Outperform |
2017-11-09 | 繰り返されました | RBC Capital Mkts | Sector Perform |
2017-11-09 | ダウングレード | The Benchmark Company | Buy → Hold |
2017-11-08 | 繰り返されました | Mizuho | Buy |
2017-11-02 | アップグレード | The Benchmark Company | Hold → Buy |
2017-08-21 | 開始されました | BofA/Merrill | Neutral |
すべてを表示
Amedisys Inc (AMED) 最新ニュース
Director Kline Teresa L. was granted 1,690 shares, increasing direct ownership by 21% to 9,818 units (SEC Form 4) - Quantisnow
Director Capps Vickie L was granted 1,690 shares, increasing direct ownership by 21% to 9,818 units (SEC Form 4) - Quantisnow
Director Samuels Ivanetta Davis was granted 1,690 shares, increasing direct ownership by 29% to 7,600 units (SEC Form 4) - Quantisnow
UnitedHealth, Amedisys reach new deal to sell home health and hospice locations if merger approved - Healthcare Dive
Amedisys Deal Would Bring BrightSpring Into Range of New Markets - Hospice News
UnitedHealth, Amedisys strike deals to sell home care locations - Modern Healthcare
Press Release Distribution & PR Platform - ACCESS Newswire
Amedisys to Divest Hospice, Home Health Locations to BrightSpring, The Pennant Group - Hospice News
Amedisys (AMED) Boosts Sale Prospects with Divestiture Plan - GuruFocus
Amedisys gains after announcing new divestiture agreements in UnitedHealth deal - Seeking Alpha
Decoding Amedisys Inc (AMED): A Strategic SWOT Insight - GuruFocus
UnitedHealth: Q1 Decline Makes Undervalued Stock a Strong Buy With Dividend Upside - Investing.com
AMEDISYS INC SEC 10-Q Report - TradingView
AMED Stock Trades Flat Despite Q1 Earnings Beat, Margins Rise - TradingView
Amedisys: Q1 Earnings Snapshot - MySA
Amedisys Reports Strong Q1 2025 Financial Results - TipRanks
Compared to Estimates, Amedisys (AMED) Q1 Earnings: A Look at Key Metrics - Yahoo Finance
AMEDISYS Earnings Results: $AMED Reports Quarterly Earnings - Nasdaq
Amedisys Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Amedisys (AMED) Tops Q1 Earnings Estimates - Yahoo Finance
Amedisys Inc Q1 2025 Earnings: EPS of $1.84 Beats Estimates, Rev - GuruFocus
Amedisys Reports First Quarter 2025 Financial Results - The Manila Times
Amedisys Extends Credit Facility Amid Merger Talks - TipRanks
Amedisys Q1 Profit Increases, Beats Estimates - Nasdaq
Amedisys Reports First Quarter 2025 Financial Results | AMED Sto - GuruFocus
Earnings Flash (AMED) AMEDISYS INC. Reports Q1 Adjusted EPS $1.25, vs. FactSet Est of $1.11 - marketscreener.com
Amedisys, Inc. Reports Strong Q1 2025 Financial Results with Significant Revenue and Net Income Growth - Nasdaq
US settlement talks begin in UnitedHealth-Amedisys merger case - MLex
Amedisys: 2Q Earnings Snapshot - marketscreener.com
Amedisys (AMED) Earnings Expected to Grow: Should You Buy? - Yahoo Finance
UnitedHealth to enter mediation with DOJ over Amedisys deal - Healthcare Dive
DOJ, UnitedHealth-Amedisys lawsuit headed to mediation - Modern Healthcare
DOJ's Lawsuit Against Amedisys, UnitedHealth Group Set for Mediation - Hospice News
UnitedHealth Group, Amedisys will head to mediation with DOJ over merger - Fierce Healthcare
Shareholder Alert: Ademi LLP investigates whether Amedisys, Inc. has obtained a Fair Price in its transaction with Option Care Health - marketscreener.com
Amedisys Gets Merger Filing Claim Paused In DOJ's UHG Suit - Law360
Monthly Merger Review Snapshot - Law360
Cantor Fitzgerald maintains Amedisys stock at Neutral, $101 target By Investing.com - Investing.com Canada
Lobbying Update: $50,000 of AMEDISYS HOME HEALTH AND HOSPICE CARE lobbying was just disclosed - Nasdaq
Why Is Amedisys (AMED) Up 1.3% Since Last Earnings Report? - Yahoo Finance
Amedisys’ home health volume increases by 5% for Q4 2020 as profits soar by 63% - McKnight's Senior Living
Oppenheimer moving to Perform from Not Rated on Amedisys - TipRanks
US Bancorp DE Boosts Holdings in Amedisys, Inc. (NASDAQ:AMED) - Defense World
Raymond James maintains Amedisys stock Market Perform rating By Investing.com - Investing.com Canada
Raymond James maintains Amedisys stock Market Perform rating - Investing.com
Amedisys, Inc. (NASDAQ:AMED) Shares Purchased by Bank of New York Mellon Corp - Defense World
Mutual of America Capital Management LLC Has $1.57 Million Stake in Amedisys, Inc. (NASDAQ:AMED) - Defense World
Amedisys Inc (AMED) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):